Impact? Nope, don't worry, be happy, says Linux veteran Opinion There has been considerable worry about the impact of the ...
Boehringer Ingelheim has moved one of its top pipeline prospects – oral phosphodiesterase 4B (PDE4B) inhibitor BI 1015550 – into late-stage clinical testing for idiopathic pulmonary fibrosis and other ...